FemmePharma Global Healthcare, founded in 1996 and based in Wayne, Pennsylvania, is dedicated to developing pharmaceutical-grade solutions for women's health. The company focuses on therapeutic regimens for conditions like urinary incontinence, mastalgia, dysmenorrhea, dysfunctional uterine bleeding, endometriosis, and sexually transmitted diseases/HIV. Their mission emphasizes creating healthcare products by women scientists to address the unique medical needs of women globally.
FemmePharma has made significant strides in women's healthcare through its patented and highly targeted drug delivery technologies. The company's impact is evident in its commitment to addressing prevalent conditions such as vaginal atrophy, fibrocystic breast disease, and overactive bladder. By focusing on innovative treatments, FemmePharma has positioned itself as a leader in the women's health sector, contributing to improved quality of life for millions of women.